Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone

Johnson, Nathalie A.; Holcroft, Christina; Ott, German

dc.contributor.author	Ott, German
dc.date.accessioned	2015-06-15T11:55:34Z
dc.date.available	2015-06-15T11:55:34Z
dc.date.issued	2012
dc.identifier.issn	0732-183X
dc.identifier.uri	http://hdl.handle.net/10900/63638
dc.language.iso	en	de_DE
dc.publisher	Alexandria, Va. : American Society of Clinical Oncology	de_DE
dc.relation.uri	http://dx.doi.org/10.1200/JCO.2011.41.0985	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone	de_DE
dc.type	Article	de_DE
utue.publikation.seiten	3452-3459	de_DE
utue.personen.roh	Johnson, Nathalie A.
utue.personen.roh	Holcroft, Christina
utue.personen.roh	Ott, German
dcterms.isPartOf.ZSTitelID	Journal of clinical oncology	de_DE
dcterms.isPartOf.ZS-Issue	28	de_DE
dcterms.isPartOf.ZS-Volume	30	de_DE